Cargando…

Predictors and prevention of diabetic cardiomyopathy

Despite our cognizance that diabetes can enhance the chances of heart failure, causes multiorgan failure,and contributes to morbidity and mortality, it is rapidly increasing menace worldwide. Less attention has been paid to alert prediabetics through determining the comprehensive predictors of diabe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chavali, Vishalakshi, Tyagi, Suresh C, Mishra, Paras K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629872/ https://www.ncbi.nlm.nih.gov/pubmed/23610527 http://dx.doi.org/10.2147/DMSO.S30968

Ejemplares similares

Exercise ameliorates high fat diet induced cardiac dysfunction by increasing interleukin 10
por: Kesherwani, Varun, et al.
Publicado: (2015)

Ablation of Matrix Metalloproteinase-9 Prevents Cardiomyocytes Contractile Dysfunction in Diabetics
por: Prathipati, Priyanka, et al.
Publicado: (2016)

Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol
por: Mishra, Paras K, et al.
Publicado: (2010)

Diabetic Cardiomyopathy: An Immunometabolic Perspective
por: Mishra, Paras K., et al.
Publicado: (2017)

Transgenic Expression of miR-133a in the Diabetic Akita Heart Prevents Cardiac Remodeling and Cardiomyopathy
por: Kambis, Tyler N., et al.
Publicado: (2019)

Regulating Polyamine Metabolism by miRNAs in Diabetic Cardiomyopathy
por: Kambis, Tyler N., et al.
Publicado: (2021)

MicroRNAs as a therapeutic target for cardiovascular diseases
por: Mishra, Paras Kumar, et al.
Publicado: (2009)

Role of Oxidative Stress in Diabetic Cardiomyopathy
por: De Geest, Bart, et al.
Publicado: (2022)

Exercise Training Promotes Cardiac Hydrogen Sulfide Biosynthesis and Mitigates Pyroptosis to Prevent High-Fat Diet-Induced Diabetic Cardiomyopathy
por: Kar, Sumit, et al.
Publicado: (2019)

Diabetic Cardiomyopathy and Its Prevention by Nrf2: Current Status
por: Chen, Jing, et al.
Publicado: (2014)

Hydrogen Sulfide Mitigates Cardiac Remodeling During Myocardial Infarction via Improvement of Angiogenesis
por: Qipshidze, Natia, et al.
Publicado: (2012)

Prevention of Diabetic Complications by Activation of Nrf2: Diabetic Cardiomyopathy and Nephropathy
por: Li, Bing, et al.
Publicado: (2012)

Diabetic Cardiomyopathy and Ischemic Heart Disease: Prevention and Therapy by Exercise and Conditioning
por: Crisafulli, Antonio, et al.
Publicado: (2020)

The Importance of SGLT-2 Inhibitors as Both the Prevention and the Treatment of Diabetic Cardiomyopathy
por: Kowalska, Klaudia, et al.
Publicado: (2022)

Diabetic cardiomyopathy
por: Asghar, Omar, et al.
Publicado: (2009)

SGLT2 Inhibitors: A Novel Player in the Treatment and Prevention of Diabetic Cardiomyopathy
por: Li, Na, et al.
Publicado: (2020)

Intimal redox stress: Accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy
por: Hayden, Melvin R, et al.
Publicado: (2002)

Homocysteine and Hypertension in Diabetes: Does PPARγ Have a Regulatory Role?
por: Sen, Utpal, et al.
Publicado: (2010)

The Role of Mitochondrial Abnormalities in Diabetic Cardiomyopathy
por: Dabravolski, Siarhei A., et al.
Publicado: (2022)

Can We Prevent Mitochondrial Dysfunction and Diabetic Cardiomyopathy in Type 1 Diabetes Mellitus? Pathophysiology and Treatment Options
por: Cieluch, Aleksandra, et al.
Publicado: (2020)

Diagnostic approaches for diabetic cardiomyopathy
por: Lorenzo-Almorós, A., et al.
Publicado: (2017)

Mitochondrial Mechanisms in Diabetic Cardiomyopathy
por: Gollmer, Johannes, et al.
Publicado: (2020)

Role of inflammation in diabetic cardiomyopathy
por: Ramesh, Pranav, et al.
Publicado: (2022)

Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation
por: Hayden, Melvin R, et al.
Publicado: (2004)

Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: The pleiotropic effects of folate supplementation
por: Hayden, Melvin R, et al.
Publicado: (2004)

Impaired Folate-Mediated One-Carbon Metabolism in Type 2 Diabetes, Late-Onset Alzheimer’s Disease and Long COVID
por: Hayden, Melvin R., et al.
Publicado: (2021)

Diabetic Cardiomyopathy: Does the Type of Diabetes Matter?
por: Hölscher, Maximilian E., et al.
Publicado: (2016)

Electrocardiographic predictors of peripartum cardiomyopathy
por: Karaye, Kamilu M, et al.
Publicado: (2016)

Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle
por: Hayden, Melvin R, et al.
Publicado: (2004)

Left ventricular reverse remodelling and its predictors in non‐ischaemic cardiomyopathy
por: Hnat, Tomas, et al.
Publicado: (2022)

Clinical and Echocardiographic Predictors of Mortality in Chagasic Cardiomyopathy - Systematic Review
por: Pereira, Clodoval de Barros, et al.
Publicado: (2014)

Evidence for human diabetic cardiomyopathy
por: Marfella, Raffaele, et al.
Publicado: (2021)

Non-Invasive Imaging in Diabetic Cardiomyopathy
por: Mordi, Ify R.
Publicado: (2019)

Established and Emerging Mechanisms of Diabetic Cardiomyopathy
por: Gollmer, Johannes, et al.
Publicado: (2019)

Application of Animal Models in Diabetic Cardiomyopathy
por: Lee, Wang-Soo, et al.
Publicado: (2021)

Role of novel biomarkers in diabetic cardiomyopathy
por: Kumric, Marko, et al.
Publicado: (2021)

CD36 Signaling in Diabetic Cardiomyopathy
por: Zhang, Xudong, et al.
Publicado: (2021)

My Sweetheart Is Broken: Role of Glucose in Diabetic Cardiomyopathy
por: Brahma, Manoja K., et al.
Publicado: (2017)

Differing strategies for sudden death prevention in hypertrophic cardiomyopathy
por: Maron, Martin S, et al.
Publicado: (2023)

Clinical Profi le and Predictors of Outcomes of Patients with Peripartum Cardiomyopathy: The Philippine Heart Center Experience
por: Cuenza, Lucky R., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_sd91mspdg1sridqqakgo29orf9